Literature DB >> 30548099

Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.

Xueling Suo1, Du Lei1,2, Lan Cheng3, Nannan Li3, Panli Zuo4, Danny J J Wang5, Xiaoqi Huang1, Su Lui1, Graham J Kemp6, Rong Peng3, Qiyong Gong1.   

Abstract

Mild cognitive impairment (MCI), a well-defined nonmotor manifestation of Parkinson's disease (PD), greatly impairs functioning and quality of life. However, the contribution of cerebral perfusion, quantified by arterial spin labeling (ASL), to MCI in PD remains poorly understood. The selection of an optimal delay time is difficult for single-delay ASL, a problem which is avoided by multidelay ASL. This study uses a multidelay multiparametric ASL to investigate cerebral perfusion including cerebral blood flow (CBF) and arterial transit time (ATT) in early stage PD patients exhibiting MCI using a voxel-based brain analysis. Magnetic resonance imaging data were acquired on a 3.0 T system at rest in 39 early stage PD patients either with MCI (PD-MCI, N = 22) or with normal cognition (PD-N, N = 17), and 36 age- and gender-matched healthy controls (HCs). CBF and ATT were compared among the three groups with SPM using analysis of variance followed by post hoc analyses to define regional differences and examine their relationship to clinical data. PD-MCI showed prolonged ATT in right thalamus compared to both PD-N and HC, and in right supramarginal gyrus compared to HC. PD-N showed shorter ATT in left superior frontal cortex compared to HC. Prolonged ATT in right thalamus was negatively correlated with the category fluency test (p = .027, r = -0.495) in the PD-MCI group. This study shows that ATT may be a more sensitive marker than CBF for the MCI, and highlights the potential role of thalamus and inferior parietal region for MCI in early stage PD.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson's disease; arterial spin labeling; arterial transit time; cerebral blood flow; mild cognitive impairment; multidelay

Mesh:

Substances:

Year:  2018        PMID: 30548099      PMCID: PMC6865659          DOI: 10.1002/hbm.24451

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  67 in total

1.  Corticolimbic gray matter loss in Parkinson's disease without dementia.

Authors:  Y Nishio; K Hirayama; A Takeda; Y Hosokai; T Ishioka; K Suzuki; Y Itoyama; S Takahashi; E Mori
Journal:  Eur J Neurol       Date:  2010-03-09       Impact factor: 6.089

2.  Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.

Authors:  Su Jin Chung; Jeong-Hyeon Shin; Kyoo Ho Cho; Yoonju Lee; Young H Sohn; Joon-Kyung Seong; Phil Hyu Lee
Journal:  Mov Disord       Date:  2017-07-24       Impact factor: 10.338

Review 3.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

4.  Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson's disease.

Authors:  Zoe Joanna Syrimi; Lubomir Vojtisek; Ilona Eliasova; Jana Viskova; Alena Svatkova; Jiri Vanicek; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-03-07       Impact factor: 3.575

5.  Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI.

Authors:  María A Fernández-Seara; Elisa Mengual; Marta Vidorreta; Maite Aznárez-Sanado; Francis R Loayza; Federico Villagra; Jaione Irigoyen; María A Pastor
Journal:  Neuroimage       Date:  2011-10-18       Impact factor: 6.556

6.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

7.  Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.

Authors:  Xixi Wang; Jiejin Zhang; Yongsheng Yuan; Tiannv Li; Li Zhang; Jian Ding; Siming Jiang; Junyi Li; Lin Zhu; Kezhong Zhang
Journal:  Neurosci Lett       Date:  2017-06-01       Impact factor: 3.046

8.  Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease.

Authors:  Joana B Pereira; Carme Junqué; María-Jośe Martí; Blanca Ramirez-Ruiz; Nuria Bargalló; Eduardo Tolosa
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

9.  Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans.

Authors:  Stéphane Lehéricy; Mathieu Ducros; Pierre-François Van de Moortele; Chantal Francois; Lionel Thivard; Cyril Poupon; Nick Swindale; Kamil Ugurbil; Dae-Shik Kim
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

10.  Arterial spin labeling reveals relationships between resting cerebral perfusion and motor learning in Parkinson's disease.

Authors:  Amy Barzgari; Jitka Sojkova; N Maritza Dowling; Vincent Pozorski; Ozioma C Okonkwo; Erika J Starks; Jennifer Oh; Frances Thiesen; Alexandra Wey; Christopher R Nicholas; Sterling Johnson; Catherine L Gallagher
Journal:  Brain Imaging Behav       Date:  2019-06       Impact factor: 3.978

View more
  8 in total

1.  Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.

Authors:  Xueling Suo; Du Lei; Lan Cheng; Nannan Li; Panli Zuo; Danny J J Wang; Xiaoqi Huang; Su Lui; Graham J Kemp; Rong Peng; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2018-12-07       Impact factor: 5.038

Review 2.  Global Alterations of Whole Brain Structural Connectome in Parkinson's Disease: A Meta-analysis.

Authors:  Chao Zuo; Xueling Suo; Huan Lan; Nanfang Pan; Song Wang; Graham J Kemp; Qiyong Gong
Journal:  Neuropsychol Rev       Date:  2022-09-20       Impact factor: 6.940

3.  Cortical hypoperfusion in patients with idiopathic rapid eye movement sleep behavior disorder detected with arterial spin-labeled perfusion MRI.

Authors:  Yonglu Chen; Changhe Fan; Wanqun Yang; Kun Nie; Xiaoling Wu; Yuelong Yang; Yunjun Yang; Lijuan Wang; Yuhu Zhang; Biao Huang
Journal:  Neurol Sci       Date:  2019-12-02       Impact factor: 3.307

Review 4.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

5.  Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge.

Authors:  Davide Maria Cammisuli; Salvatore Massimiliano Cammisuli; Jonathan Fusi; Ferdinando Franzoni; Carlo Pruneti
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

6.  Altered Prefrontal Blood Flow Related With Mild Cognitive Impairment in Parkinson's Disease: A Longitudinal Study.

Authors:  Jian Wang; Wei Zhang; Ying Zhou; Jia Jia; Yuanfang Li; Kai Liu; Zheng Ye; Lirong Jin
Journal:  Front Aging Neurosci       Date:  2022-07-11       Impact factor: 5.702

7.  Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling.

Authors:  Michael J Firbank; John T O'Brien; Rory Durcan; Louise M Allan; Sally Barker; Joanna Ciafone; Paul C Donaghy; Calum A Hamilton; Sarah Lawley; Jim Lloyd; Gemma Roberts; John-Paul Taylor; Alan J Thomas
Journal:  J Neurol       Date:  2020-10-21       Impact factor: 4.849

8.  Topologically convergent and divergent morphological gray matter networks in early-stage Parkinson's disease with and without mild cognitive impairment.

Authors:  Xueling Suo; Du Lei; Nannan Li; Junying Li; Jiaxin Peng; Wenbin Li; Jing Yang; Kun Qin; Graham J Kemp; Rong Peng; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2021-07-28       Impact factor: 5.038

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.